A great case study for a mid-sized IP portfolio for a medical devices company

As part of its role in raising awareness of good IP practice, the European Patent Office has  recently prepared some very good case studies on company IP portfolios. Based on my experience, I particularly like this one on the Irish company Aerogen, which has aerosol drug delivery technology, and I recommend it to mid-size companies, and ambitious small companies`:
http://documents.epo.org/projects/babylon/eponet.nsf/0/9F75BC8BD2455394C12581790042486E/$File/sme_case_study_aerogen_en.pdf
The case study explains that Aerogen has 14 patent families, other IP is not covered in detail. 
Features of the case study that particularly resonated with me, based on similar situations, included:

• active management of the portfolio and exploitation of the portfolio through licensing 
• using a network of advisers in different important markets (here Ireland, Germany and USA)
• processes in relation to internal IP development and external IP threats
• regular meetings with the external patent attorneys  
• taking ownership of IP developed in collaborations 
• and most significantly, senior management buy in and understanding of the portfolio and its relationship with the business’ objectives.